Allergic rhinitis - Portfolio Pages

Document Sample
Allergic rhinitis - Portfolio Pages Powered By Docstoc
The Activities on these Portfolio Pages correspond with the learning objectives
of the Guided Learning unit published in Nursing Times 105: 30 (4 August,
2009). The full reference list for this unit follows Activity 2.

Before starting to work through these Activities, save this document onto your
computer, then print the completed work for your professional portfolio.
Alternatively, simply print the pages if you prefer to work on paper, using extra
sheets as necessary.

Recording your continuing professional education
To make your work count as part of your five days’ CPD for each registration
period, make a note in the box below of the date and the total number of hours
you spent on reading the unit and any other relevant material, and working
through the Activities.

 Hours:                         Date:


Learning objective: Know how to
diagnose allergic rhinitis.

Activity: Outline the process to follow
when diagnosing allergic rhinitis.


Begin your response here.

Nursing Times Portfolio Pages: Allergic rhinitis                              11    1

ACTIVITY 2                                         options and their efficacy in treating AR.

Learning objective: Be aware of the                RESPONSE
treatment options and their efficacy in
treating AR.                                       Begin your response here.

Activity: Describe the various treatment

Nursing Times Portfolio Pages: Allergic rhinitis                                         22     2

REFERENCES                                         109: 251–256.
                                                   Pham-Thi, N. et al (2006) Sublingual
                                                   immunotherapy in the treatment of children.
Allen, D.B. et al (2002) No growth                 Allergy; 61 (suppl 81): 7–10.
suppression in children treated with the           Philip, G. et al (2004) The effect of
maximum recommended dose of                        montelukast on rhinitis symptoms in
fluticasone propionate aqueous nasal spray         patients with asthma and seasonal allergic
for one year. Allergy and Asthma                   rhinitis. Current Medical Research and
Proceedings; 23: 407–413.                          Opinion; 20: 1549–1558.
Baena-Cagnani, C.E. (2004) Safety and              Scadding, G.K. et al (2008) BSACI
tolerability of treatments for allergic rhinitis   guidelines for the management of allergic
in children. Drug Safety; 27: 883–898.             and non-allergic rhinitis. Clinical and
Bousquet, J. et al (2008) Allergic rhinitis        Experimental Allergy; 38: 1, 19–42.
and its impact on asthma (ARIA) 2008               Schenkel, E.J. et al (2000) Absence of
update (in collaboration with the World            growth retardation in children with perennial
Health Organization, GA(2)LEN and                  AR after one year of treatment with
AllerGen). Allergy; 63: Suppl 86: 8–160.           mometasone furoate aqueous nasal spray.
Bousquet, J. et al (2001) Allergic rhinitis        Pediatrics; 105: e22.
and its impact on asthma. The Journal of           Spiegel, J. et al (2006) The Inner-City
Allergy and Clinical Immunology; 108: (5           Asthma Intervention: description of a
Suppl), S147–334.                                  community-based implementation of an
Braunstahl, G.J. et al (2001) Nasal                evidence-based approach to asthma
allergen provocation induces adhesion              management. Annals of Allergy, Asthma
molecule expression and tissue                     and Immunology; 97: 1 Suppl 1, S6–S10.
eosinophilia in upper and lower airways.           Thomas, M. et al (2005) Asthma-related
The Journal of Allergy and Clinical                health care resource use among asthmatic
Immunology; 107: 469–76.                           children with and without concomitant
Daley-Yates, P.T., Richards, D.H. (2004)           allergic rhinitis. Pediatrics; 115: 129–134.
Relationship between systemic                      Vignola, A.M. et al (2004) Efficacy and
corticosteroid exposure and growth                 tolerability of anti-immunoglobulin E
velocity: development and validation of a          therapy with omalizumab in patients with
pharmacokinetic/pharmacodynamic model.             concomitant allergic asthma and persistent
Clinical Therapeutics; 26: 11, 1905–1919.          allergic rhinitis: SOLAR. Allergy; 59: 709–
Li, H. et al (2009) Nasal saline irrigation        717.
facilitates control of allergic rhinitis by        Vuurman, E.F. et al (1993) Seasonal AR
topical steroid in children. Journal for Oto-      and antihistamine effects on children’s
rhino-laryngology, Head and Neck Surgery;          learning. Annals of Allergy; 71: 121–126.
71: 1, 50–55.
Minshall, E. et al (1998) Assessment by
nasal biopsy of long-term use of
mometasone furoate aqueous nasal spray
(Nasonex) in the treatment of perennial
rhinitis. Otolaryngology, Head and Neck
Surgery; 118: 5, 648–54.
Moller, C. et al (2002) Pollen
immunotherapy reduces the development
of asthma in children with seasonal
rhinoconjunctivitis (the PAT study). The
Journal of Allergy and Clinical Immunology;

Nursing Times Portfolio Pages: Allergic rhinitis                                          3   3

Shared By: